AU Stock MarketDetailed Quotes

HPC The Hydration Pharmaceuticals Co Ltd

Watchlist
  • 0.009
  • 0.0000.00%
20min DelayMarket Closed Jul 4 11:30 AET
2.74MMarket Cap-152P/E (Static)

The Hydration Pharmaceuticals Co Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 30, 2023
(FY)Dec 30, 2022
(FY)Dec 30, 2021
Total revenue
10.34%10.04M
48.52%9.1M
6.13M
Operating revenue
10.34%10.04M
48.52%9.1M
--6.13M
Cost of revenue
5.58%4.65M
31.94%4.4M
3.34M
Gross profit
14.81%5.39M
68.35%4.7M
2.79M
Operating expense
-14.71%13.13M
49.70%15.4M
10.29M
Selling and administrative expenses
-14.71%13.13M
60.07%15.4M
--9.62M
-Selling and marketing expense
-25.80%6.85M
82.34%9.23M
--5.06M
-General and administrative expense
1.88%6.29M
35.36%6.17M
--4.56M
Depreciation amortization depletion
----
----
--3.34K
-Depreciation and amortization
----
----
--3.34K
Other operating expenses
----
----
--663.28K
Operating profit
27.66%-7.74M
-42.76%-10.7M
-7.5M
Net non-operating interest income (expenses)
-604.92%-642.9K
96.82%-91.2K
-2.87M
Non-operating interest income
----
-94.62%5
--93
Non-operating interest expense
604.88%642.9K
-96.82%91.21K
--2.87M
Other net income (expenses)
51.98%282.4K
-86.83%185.82K
1.41M
Other non-operating income (expenses)
51.98%282.4K
-86.83%185.82K
--1.41M
Income before tax
23.61%-8.1M
-18.49%-10.61M
-8.95M
Income tax
0
0
0
Earnings from equity interest net of tax
Net income
23.61%-8.1M
-18.49%-10.61M
-8.95M
Net income continuous operations
23.61%-8.1M
-18.49%-10.61M
---8.95M
Noncontrolling interests
Net income attributable to the company
23.61%-8.1M
-18.49%-10.61M
-8.95M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
23.61%-8.1M
-18.49%-10.61M
-8.95M
Diluted earnings per share
36.71%-0.04
45.67%-0.0632
-0.1163
Basic earnings per share
36.71%-0.04
45.67%-0.0632
-0.1163
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 30, 2023(FY)Dec 30, 2022(FY)Dec 30, 2021
Total revenue 10.34%10.04M48.52%9.1M6.13M
Operating revenue 10.34%10.04M48.52%9.1M--6.13M
Cost of revenue 5.58%4.65M31.94%4.4M3.34M
Gross profit 14.81%5.39M68.35%4.7M2.79M
Operating expense -14.71%13.13M49.70%15.4M10.29M
Selling and administrative expenses -14.71%13.13M60.07%15.4M--9.62M
-Selling and marketing expense -25.80%6.85M82.34%9.23M--5.06M
-General and administrative expense 1.88%6.29M35.36%6.17M--4.56M
Depreciation amortization depletion ----------3.34K
-Depreciation and amortization ----------3.34K
Other operating expenses ----------663.28K
Operating profit 27.66%-7.74M-42.76%-10.7M-7.5M
Net non-operating interest income (expenses) -604.92%-642.9K96.82%-91.2K-2.87M
Non-operating interest income -----94.62%5--93
Non-operating interest expense 604.88%642.9K-96.82%91.21K--2.87M
Other net income (expenses) 51.98%282.4K-86.83%185.82K1.41M
Other non-operating income (expenses) 51.98%282.4K-86.83%185.82K--1.41M
Income before tax 23.61%-8.1M-18.49%-10.61M-8.95M
Income tax 000
Earnings from equity interest net of tax
Net income 23.61%-8.1M-18.49%-10.61M-8.95M
Net income continuous operations 23.61%-8.1M-18.49%-10.61M---8.95M
Noncontrolling interests
Net income attributable to the company 23.61%-8.1M-18.49%-10.61M-8.95M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 23.61%-8.1M-18.49%-10.61M-8.95M
Diluted earnings per share 36.71%-0.0445.67%-0.0632-0.1163
Basic earnings per share 36.71%-0.0445.67%-0.0632-0.1163
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg